A Phase I Study of TPI 287 - Temozolomide Combination in Melanoma
- First Posted Date
- 2010-02-11
- Last Posted Date
- 2017-07-21
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 21
- Registration Number
- NCT01067066
- Locations
- πΊπΈ
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Phase II Study of Tesetaxel in Metastatic Melanoma
- First Posted Date
- 2010-02-08
- Last Posted Date
- 2018-07-17
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 17
- Registration Number
- NCT01064713
- Locations
- πΊπΈ
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Combination Chemotherapy With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck
- Conditions
- Recurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Oral Cavity Squamous Cell CarcinomaStage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7Stage IVA Hypopharyngeal Squamous Cell Carcinoma AJCC v7Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7Stage IVB Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7Metastatic Squamous Cell Carcinoma of the OropharynxStage IVB Hypopharyngeal Squamous Cell Carcinoma AJCC v7Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7Metastatic Squamous Cell Carcinoma of the Hypopharynx
- Interventions
- Other: Laboratory Biomarker AnalysisOther: PlaceboOther: Pharmacological StudyOther: Quality-of-Life Assessment
- First Posted Date
- 2010-02-08
- Last Posted Date
- 2024-07-16
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 123
- Registration Number
- NCT01064479
- Locations
- πΊπΈ
MD Anderson Regional Care Center-Bay Area, Nassau Bay, Texas, United States
πΊπΈMD Anderson Regional Care Center-Sugar Land, Sugar Land, Texas, United States
πΊπΈMD Anderson Regional Care Center-The Woodlands, The Woodlands, Texas, United States
Phase II Trial of Erlotinib, Prior to Surgery or Radiation in Patients With Squamous Cell Cancers (SCC) of the Skin
- First Posted Date
- 2010-01-29
- Last Posted Date
- 2017-04-04
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 10
- Registration Number
- NCT01059305
- Locations
- πΊπΈ
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
HAI Abraxane With Gemcitabine and Bevacizumab
- Conditions
- Advanced Cancers
- Interventions
- First Posted Date
- 2010-01-27
- Last Posted Date
- 2015-11-18
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 78
- Registration Number
- NCT01057264
- Locations
- πΊπΈ
UT MD Anderson Cancer Center, Houston, Texas, United States
Docetaxel and Sirolimus in Patients With Advanced Malignancies
- Conditions
- Advanced Cancer
- Interventions
- First Posted Date
- 2010-01-22
- Last Posted Date
- 2015-10-07
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 103
- Registration Number
- NCT01054313
- Locations
- πΊπΈ
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Reducing Symptom Burden - Non Small Cell Lung Cancer (NSCLC)
- Conditions
- Non Small Cell Lung Cancer
- Interventions
- First Posted Date
- 2010-01-14
- Last Posted Date
- 2015-03-05
- Lead Sponsor
- M.D. Anderson Cancer Center
- Registration Number
- NCT01048983
Conservative Surgery in Treating Patients With Low-Risk Stage IA2 or IB1 Cervical Cancer
- Conditions
- Cervical AdenocarcinomaCervical Squamous Cell Carcinoma, Not Otherwise SpecifiedStage IA2 Cervical Cancer AJCC v6 and v7Stage IB1 Cervical Cancer AJCC v6 and v7
- Interventions
- Procedure: Lymph Node MappingOther: Quality-of-Life AssessmentProcedure: Salpingo-OophorectomyProcedure: Sentinel Lymph Node BiopsyProcedure: Therapeutic Conventional Surgery
- First Posted Date
- 2010-01-14
- Last Posted Date
- 2025-05-02
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 137
- Registration Number
- NCT01048853
- Locations
- πΊπΈ
Baptist MD Anderson Cancer Center, Jacksonville, Florida, United States
πΊπΈNorthwell Health Imbert Cancer Center, Bay Shore, New York, United States
π¦πΊRoyal Women's Hosptial, Victoria, Parkville, Australia
Symptom Burden in Chronic Myeloid Leukemia (CML)
- Conditions
- Leukemia
- Interventions
- Behavioral: Interview & QuestionnairesBehavioral: Rating QuestionnaireBehavioral: MDASI-CML Questionnaire
- First Posted Date
- 2010-01-11
- Last Posted Date
- 2020-01-07
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 210
- Registration Number
- NCT01046305
- Locations
- πΊπΈ
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Study of Weekly LOC-paclitaxel Injection for Melanoma
- First Posted Date
- 2009-12-25
- Last Posted Date
- 2016-10-27
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 37
- Registration Number
- NCT01039844
- Locations
- πΊπΈ
University of Texas MD Anderson Cancer Center, Houston, Texas, United States